Simon G A Brown Selected Research

Ant Venoms

2/2022	Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.
7/2011	Causes of ant sting anaphylaxis in Australia: the Australian Ant Venom Allergy Study.
1/2011	Using time-resolved fluorescence to measure serum venom-specific IgE and IgG.
1/2011	Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy.
1/2008	Myrmecia pilosula (Jack Jumper) ant venom: validation of a procedure to standardise an allergy vaccine.
2/2006	Anaphylaxis to bull dog ant and jumper ant stings around Perth, Western Australia.
12/2003	Prevention of anaphylaxis with ant venom immunotherapy.
3/2003	Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial.
1/2003	Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon G A Brown Research Topics

Disease

22	Anaphylaxis (Anaphylactic Shock) 02/2022 - 03/2003
16	Snake Bites (Snake Bite) 02/2022 - 04/2004
16	Hypersensitivity (Allergy) 02/2022 - 01/2003
13	Bites and Stings (Sting) 02/2022 - 03/2003
11	Disseminated Intravascular Coagulation 02/2022 - 01/2007
7	Myotoxicity 02/2017 - 08/2009
6	Hypotension (Low Blood Pressure) 01/2017 - 04/2006
5	Sepsis (Septicemia) 07/2017 - 01/2014
3	Thrombotic Microangiopathies 02/2022 - 09/2010
3	Pneumothorax 01/2020 - 07/2013
3	Septic Shock (Toxic Shock Syndrome) 07/2017 - 01/2014
3	Shock 07/2017 - 05/2007
3	Human Influenza (Influenza) 01/2013 - 07/2011
2	Infarction (Infarctions) 01/2017 - 02/2013
2	Urticaria (Hives) 01/2016 - 03/2003
2	Myalgia 01/2016 - 08/2009
2	Myocardial Infarction 04/2014 - 02/2013
2	Acute Coronary Syndrome 04/2014 - 02/2013
2	Hypoglycemia (Reactive Hypoglycemia) 04/2011 - 05/2010
2	Bradycardia 04/2006 - 08/2005
1	Venom Hypersensitivity 02/2022
1	Infections 07/2017
1	Thrombocytopenia (Thrombopenia) 02/2017
1	Acute Kidney Injury (Acute Renal Failure) 02/2017
1	Inflammation (Inflammations) 01/2017
1	Arthralgia (Joint Pain) 01/2016
1	Vomiting 01/2016
1	Headache (Headaches) 01/2016
1	Fever (Fevers) 01/2016
1	Exanthema (Rash) 01/2016
1	Nausea 01/2016
1	Serum Sickness 01/2016
1	Spider Bites (Spider Bite) 12/2014
1	Pain (Aches) 12/2014
1	Drug Hypersensitivity (Drug Allergy) 07/2014
1	Lung Diseases (Lung Disease) 11/2013
1	Chest Pain (Chest Pains) 02/2013
1	Heart Arrest (Cardiac Arrest) 06/2012
1	Type 2 Diabetes Mellitus (MODY) 04/2011
1	Immediate Hypersensitivity 12/2010
1	Muscle Weakness 12/2010

Drug/Important Bio-Agent (IBA)

22	VenomsIBA 02/2022 - 02/2004
16	Antivenins (Antivenoms)IBA 02/2017 - 04/2004
9	Ant VenomsIBA 02/2022 - 01/2003
4	Pharmaceutical PreparationsIBA 02/2022 - 09/2006
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2006
4	Epinephrine (Adrenaline)FDA LinkGeneric 11/2013 - 08/2005
4	Tryptases (Tryptase)IBA 01/2013 - 04/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 10/2009
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
3	Immunoglobulin E (IgE)IBA 01/2018 - 01/2011
3	Interleukin-10 (Interleukin 10)IBA 01/2014 - 10/2009
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2013 - 04/2004
2	Indicators and Reagents (Reagents)IBA 10/2020 - 07/2014
2	ResistinIBA 07/2017 - 01/2014
2	Lipocalin-2IBA 07/2017 - 01/2014
2	InterleukinsIBA 01/2014 - 01/2013
2	Histamine Antagonists (Antihistamines)IBA 02/2013 - 08/2009
2	CytokinesIBA 01/2013 - 10/2009
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2013 - 10/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2013 - 10/2009
2	Snake Venoms (Snake Venom)IBA 08/2012 - 01/2007
2	EnzymesIBA 01/2012 - 01/2007
2	Creatine Kinase (Creatine Phosphokinase)IBA 02/2010 - 08/2009
2	Atropine FDA LinkGeneric 04/2006 - 08/2005
1	Arthropod VenomsIBA 02/2022
1	Phospholipases (Phospholipase)IBA 10/2020
1	Phospholipases A2 (Phospholipase A2)IBA 10/2020
1	Fas Ligand Protein (Fas Ligand)IBA 01/2019
1	boldenone undecylenate (Equipoise)IBA 01/2017
1	Crystalloid SolutionsIBA 01/2017
1	S100A12 ProteinIBA 01/2017
1	Saline SolutionIBA 12/2014
1	SolutionsIBA 12/2014
1	Opioid Analgesics (Opioids)IBA 12/2014
1	TroponinIBA 04/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2014
1	Blood Proteins (Serum Proteins)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	AllergensIBA 01/2013
1	AnaphylatoxinsIBA 01/2013
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2011
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2011
1	Lanthanoid Series Elements (Lanthanides)IBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	AnticoagulantsIBA 12/2010
1	Glucose (Dextrose)FDA LinkGeneric 05/2010
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2010

Therapy/Procedure

6	Resuscitation 01/2017 - 04/2006
3	Aftercare (After-Treatment) 12/2014 - 03/2003
2	Conservative Treatment 01/2020 - 01/2016
2	Therapeutics 02/2017 - 04/2011
2	Intravenous Infusions 05/2007 - 08/2005
1	Plasma Exchange 02/2022
1	Analgesia 12/2014
1	Pleurodesis 07/2013
1	Critical Care (Surgical Intensive Care) 07/2011
1	Noninvasive Ventilation 12/2010